Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind Multicenter Study to Evaluate the Long-term Safety and Efficacy of VI-0521 Relative to Placebo in Providing and Maintaining Glycemic Control in Type 2 Diabetic Adults

NCT00600067 is registered in ClinicalTrials.gov with VIVUS LLC as lead sponsor.

NCT NCT00600067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00600067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind Multicenter Study to Evaluate the Long-term Safety and Efficacy of VI-0521 Relative to Placebo in Providing and Maintaining Glycemic Control in Type 2 Diabetic Adults
Lead sponsor
VIVUS LLC
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
November 30, 2008
Enrollment
130 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes